Bonaventura Casanova

Fernando Abril Martorell Avenue 106
Valencia, VC 46026, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Stage-Specific Gene Expression Profiles in Multiple Sclerosis Cortical Lesions Identified via Spatial Transcriptomics.

Stage-Specific Gene Expression Profiles in Multiple Sclerosis Cortical Lesions Identified via Spatial Transcriptomics.

Journal: Omics : a journal of integrative biology

Published: August 17, 2026

Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression.

Tear CHI3L1 in multiple sclerosis: a non-invasive biomarker linked to disease progression.

Journal: Multiple sclerosis and related disorders

Published: May 14, 2026

Relapse-associated versus relapse-independent progression determines disability trajectories in multiple sclerosis beyond EDSS 3.0.

Relapse-associated versus relapse-independent progression determines disability trajectories in multiple sclerosis beyond EDSS 3.0.

Journal: Multiple sclerosis and related disorders

Published: March 19, 2026

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 13, 2026

Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays.

Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays.

Journal: Frontiers in neurology

Published: August 08, 2025

An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing.

An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing.

Journal: Advances in laboratory medicine

Published: June 10, 2025

New approach to specific Alzheimer's disease diagnosis based on plasma biomarkers in a cognitive disorder cohort.

New approach to specific Alzheimer's disease diagnosis based on plasma biomarkers in a cognitive disorder cohort.

Journal: European journal of clinical investigation

Published: January 14, 2025

Correction to: Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.

Correction to: Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: December 31, 2024

Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis.

Neurofilaments: A Promising Diagnostic and Prognostic Biomarker in Multiple Sclerosis.

Journal: Annals of neurosciences

Published: December 04, 2024

Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases.

Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases.

Journal: Neurologia

Published: September 17, 2024

Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels.

Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels.

Journal: Frontiers in neurology

Published: August 07, 2024

Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report.

Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report.

Journal: Frontiers in immunology

Published: July 21, 2024

Showing 1-12 of 82

Last Updated: 09/26/2026